219 related articles for article (PubMed ID: 30353543)
21. Prognostic significance of serum uric acid in women with gestational hypertension.
Bellomo G; Venanzi S; Saronio P; Verdura C; Narducci PL
Hypertension; 2011 Oct; 58(4):704-8. PubMed ID: 21876075
[TBL] [Abstract][Full Text] [Related]
22. Significance of pregnancy-associated plasma protein A (PAPP-A) concentration determination in the assessment of final outcome of pregnancy.
Loncar D; Varjacić M; Arsenijević S
Vojnosanit Pregl; 2013 Jan; 70(1):46-50. PubMed ID: 23401929
[TBL] [Abstract][Full Text] [Related]
23. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
24. Are high uric acid levels in patients with early pre-eclampsia an indication for delivery?
Odendaal HJ; Pienaar ME
S Afr Med J; 1997 Feb; 87(2):213-8. PubMed ID: 9180815
[TBL] [Abstract][Full Text] [Related]
25. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
26. Serum urate as a predictor of fetal outcome in severe pre-eclampsia.
Sagen N; Haram K; Nilsen ST
Acta Obstet Gynecol Scand; 1984; 63(1):71-5. PubMed ID: 6720261
[TBL] [Abstract][Full Text] [Related]
27. Uric Acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia.
Livingston JR; Payne B; Brown M; Roberts JM; Côté AM; Magee LA; von Dadelszen P;
J Obstet Gynaecol Can; 2014 Oct; 36(10):870-877. PubMed ID: 25375299
[TBL] [Abstract][Full Text] [Related]
28. A cohort study of the association between maternal serum Inhibin-A and adverse pregnancy outcomes: a population-based study.
Singnoi W; Wanapirak C; Sekararithi R; Tongsong T
BMC Pregnancy Childbirth; 2019 Apr; 19(1):124. PubMed ID: 30971214
[TBL] [Abstract][Full Text] [Related]
29. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience.
Müller A; Horvat V; Vulin M; Mandić S; Šerić V; Vidosavljević D
Med Glas (Zenica); 2019 Feb; 16(1):53-59. PubMed ID: 30680983
[TBL] [Abstract][Full Text] [Related]
30. Maternal serum uric acid and calcium as predictors of hypertensive disorder of pregnancy: A case control study.
Kumar N; Singh AK
Taiwan J Obstet Gynecol; 2019 Mar; 58(2):244-250. PubMed ID: 30910147
[TBL] [Abstract][Full Text] [Related]
31. Estimation of plasma uric acid in pregnancy induced hypertension (PIH). Is the test still relevant?
Wakwe VC; Abudu OO
Afr J Med Med Sci; 1999; 28(3-4):155-8. PubMed ID: 11205821
[TBL] [Abstract][Full Text] [Related]
32. Substance abuse during pregnancy: effect on pregnancy outcomes.
Pinto SM; Dodd S; Walkinshaw SA; Siney C; Kakkar P; Mousa HA
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):137-41. PubMed ID: 20227162
[TBL] [Abstract][Full Text] [Related]
33. Salivary uric acid as a predictive test of preeclampsia, pregnancy-induced hypertension and preterm delivery: A pilot study.
Püschl IC; Bonde L; Reading IC; Maguire P; Macklon NS; Van Rijn BB
Acta Obstet Gynecol Scand; 2020 Oct; 99(10):1339-1345. PubMed ID: 32350850
[TBL] [Abstract][Full Text] [Related]
34. [Profile of serum soluble endoglin in pregnant women with severe pre-eclampsia and eclampsia].
Zhu YC; Sun Y; Yang HX; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):91-3. PubMed ID: 19570416
[TBL] [Abstract][Full Text] [Related]
35. Maternal and perinatal outcomes related to superimposed pre-eclampsia in a Brazilian cohort of women with chronic hypertension.
Casagrande L; Rezende GP; Guida JP; Costa RS; Parpinelli MA; Surita FG; Costa ML
Int J Gynaecol Obstet; 2020 May; 149(2):148-153. PubMed ID: 32037536
[TBL] [Abstract][Full Text] [Related]
36. The significance of serum uric acid, creatinine and urinary microprotein levels in predicting pre-eclampsia.
Weerasekera DS; Peiris H
J Obstet Gynaecol; 2003 Jan; 23(1):17-9. PubMed ID: 12623475
[TBL] [Abstract][Full Text] [Related]
37. Association between uric acid and severity of pre-eclampsia.
Pereira KN; Knoppka CK; da Silva JE
Clin Lab; 2014; 60(2):309-14. PubMed ID: 24660546
[TBL] [Abstract][Full Text] [Related]
38. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.
Cui L; Shu C; Liu Z; Tong W; Cui M; Wei C; Tang JJ; Liu X; Hu J; Jiang J; He J; Zhang DY; Ye F; Li Y
Pregnancy Hypertens; 2018 Jul; 13():127-132. PubMed ID: 30177039
[TBL] [Abstract][Full Text] [Related]
39. Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia.
Oztas E; Ozler S; Ersoy AO; Iskender CT; Sucak A; Ergin M; Uygur D; Danisman N
J Perinat Med; 2016 Apr; 44(3):269-75. PubMed ID: 26352072
[TBL] [Abstract][Full Text] [Related]
40. Endothelin-1 and leptin as markers of intrauterine growth restriction.
Nezar MA; el-Baky AM; Soliman OA; Abdel-Hady HA; Hammad AM; Al-Haggar MS
Indian J Pediatr; 2009 May; 76(5):485-8. PubMed ID: 19390804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
